As a UC San Diego alumnus, Kevin Churchill, ’96, already knew that the university had a reputation for cutting-edge research and advanced medical care. However, it wasn’t until his son Benny was born visually impaired that Churchill discovered the remarkable breadth of leading research taking place at his alma mater.
UC San Diego Sulpizio Cardiovascular Center experts have performed San Diego’s first-ever coronary revascularization procedure using a hybrid operating room, the only facility of its kind in the region.
UC San Diego Health Sciences has entered a period of remarkable growth, one that will strengthen its position as a destination academic medical center. In addition to the recent addition of the Sulpizio Cardiovascular Center and Medical Education & Telemedicine Building, plans are underway for the Altman Clinical and Translational Research Institute building (projected to open in 2015) and the Jacobs Medical Center (with a planned 2016 opening.)
A study using genetically modified zebrafish to visualize early events involved in development of human atherosclerosis describes an efficient model – one that the researchers say offers many applications for testing the potential effectiveness of new antioxidant and dietary therapies.
Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor.
Researchers at the University of California, San Diego School of Medicine and Kyushu University Medical School say a novel combination of a specific sugar molecule with a pair of cell-killing drugs prompts a wide variety of cancer cell types to kill themselves, a process called apoptosis or programmed cell death.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
